Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Japanese and US universities have jointly developed a medical technique that can quickly detect various cancers using a simple saliva test, researchers said Tuesday.
Japan's Keio University and University of California, Los Angeles, have developed the technology with which they detected high probabilities of pancreatic cancer, breast cancer and oral cancer.
The researchers analysed saliva samples of 215 people, including cancer patients, and identified 54 substances whose presence can be used to detect the disease, Keio University said in a statement released Monday.
By further analysing the substances, the test detected 99 percent of pancreatic cancer cases, 95 percent of breast cancer and 80 percent of oral cancer cases among those taking part, it said.
The cancer test using the technology would take half a day at the longest, the researchers said.
The new technology can detect up to 500 different substances found in saliva at one time, said professor Tomoyoshi Soga at Keio's Institute for Advanced Biosciences.
He said the technology would make it especially easier to detect pancreatic and oral cancers.
"The survival rates of pancreatic cancer and oral cancer are especially low, because they don't show clear symptoms in early stages, which often delays spotting of the illness," the statement said.
"Saliva can be sampled more easily and casually than blood or stool inspection," said institute head Masaru Tomita in the statement.
"We would like to apply this technology not only to cancer cases but also other illnesses as well," he said.
oh/dwa/pdw
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments